Talk:Tazarotene

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine: Dermatology Start‑class Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Start	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Dermatology task force.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tazarotene.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This whole article sounds like an ad. It is not neutral, and it reads like it was written by a drug rep. The lack of citations is a key factor.

Really? What part seems NPOV to you? The part where the article states what conditions the drug is approved for treating, or the part where the common side effects are listed? This article reads like a typical patient information sheet or drug advisory. --72.188.235.81 03:46, 24 August 2007 (UTC)[reply]

There are many inaccuracies in this article. Tazarotene has proven more effective than Tretinion for both acne and photoaging in any single clinical trial, of which there have been many. Just search Pubmed. It is also not true that there are only limited benefits of Tazarotene for photodamage; the effects are profound. I would find you the studies if I cared. —Preceding unsigned comment added by 91.148.156.12 (talk) 23:29, 4 September 2009 (UTC)[reply]

According to Pubmed (2018), [2], the 2007 article "Interventions for photodamaged skin" has been withdrawn, so it is not a valid citation. PMID: 15674885 — Preceding unsigned comment added by 146.200.138.39 (talk) 22:08, 8 April 2018 (UTC)[reply]